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Sarcopenia and Its Impact on Health: Do They Have Significant Associations?
(Sarkopenia dan Kesannya ke Atas Kesihatan: Adakah Terdapat Sebarang Hubung Kait?)
S.K. NORSHAFARINA, M.S. NOOR IBRAHIM*, S. SUZANA, A. MOHAMAD HASNAN, M. ZAHARA & Y. ZAITUN 
ABSTRACT
A cross sectional study was conducted to determine the prevalence of Sarcopenia and its association with health profiles 
and oxidative stress among multiethnic older adults in an urban area of Malaysia. Sarcopenia was assessed using 
Bioimpedance analysis (BIA) and the associations between demography, socioeconomic status, lifestyle practices, health 
risk factors and blood profile were examined on 388 apparently healthy subjects aged 60 years and above. Prevalence of 
sarcopenia was 89.0% in men and 40.3% in women with the overall prevalence of 59.8%. It was found that prevalence 
of severe sarcopenia was 13.9% and sarcopenia obese was 23.5%. Binary logistic regression showed that there was no 
predictor found in men or women. However, a decline in muscle mass was observed in sarcopenic as compared with 
normal subjects. Sarcopenia is prevalent and there is a need to implement interventional strategies to prevent sarcopenia 
and its associated comorbidities. 
Keywords: Elderly people; Malaysia; muscle mass; oxidative stress; sarcopenia
ABSTRAK
Satu kajian keratan lintang telah dijalankan bagi menentukan prevalens sarkopenia dan hubungannya dengan profil 
kesihatan dan tekanan oksidatif dalam kalangan warga tua multietnik di sebuah kawasan bandar di Malaysia. Sarkopenia 
dinilai menggunakan analisis bioimpedans (BIA) dan hubungannya dengan demografi, status sosioekonomi, amalan 
gaya hidup, faktor risiko kesihatan dan profil darah telah ditentukan dalam kalangan 388 subjek berusia 60 tahun dan 
ke atas yang kelihatan sihat. Prevalens sarkopenia adalah 89.0% dalam kalangan lelaki dan 40.3% dalam kalangan 
wanita, dengan prevalens keseluruhan adalah 59.8%. Didapati bahawa prevalens sarkopenia teruk adalah 13.9% dan 
sarkopenia obes adalah 23.5%. Analisis regresi logistik binari menunjukkan tiada prediktor yang dijumpai bagi lelaki 
atau wanita. Walau bagaimanapun, penurunan jisim otot berlaku dalam kalangan subjek sarkopenia berbanding subjek 
normal. Sarkopenia adalah prevalens dan terdapat keperluan bagi implementasi strategi pencelahan bagi mencegah 
sarkopenia dan komorbiditi berkaitannya. 
Kata kunci: Jisim otot; Malaysia; sarkopenia; tekanan oksidatif; warga tua
INTRODUCTION
Sarcopenia is increasingly recognized as a health problem 
among older persons (Baumgartner et al. 1998; Lau et 
al. 2005; Melton et al. 2000) and it is one of the major 
determinant factors in frailty (Baumgartner et al. 1998; 
Melton et al. 2000; Newman 2003). Losses of more 
than 40% muscle mass as frequently seen in elderly 
people with sarcopenia are associated with morbidity 
and diminished strength due to a reduction in physical 
activity and aerobic capacity. The relatively low muscle 
mass may already adversely affect quality of life and 
functional abilities (Baumgartner et al. 1998). Physical 
disability and functional limitations are common among 
older people, leading to adverse consequences such as 
dependency and institutionalization. Older people’s 
ability to function independently is important, as physical 
disability and functional limitation have profound public 
health implications with increased utilization of health 
care and a need for supportive services and long term care 
(Baumgartner et al. 1998; Morley et al. 2001). 
  The prevalence of sarcopenia among older adults in 
western countries ranged from 8.8% to 17.5% with its 
prevalence increasing with ageing. For example, in the 
New Mexico Elder Health Survey involving 426 men and 
382 women, the prevalence of sarcopenia varied from 13% 
to 24% among subjects under 70 years old to more than 
50% among those aged 80 years and above (Baumgartner 
et al. 1998). The magnitude of sarcopenia among Asian 
elderly people in Hong Kong was 7.2% in men and 
6.1% in women (Sowers et al. 2005). The discrepancy 
of the prevalence of sarcopenia might not only be due to 
differences in body composition across ethnic groups but 
also depends on the diagnostic criteria and techniques 
utilised. Furthermore, since body composition varies 
among ethnic groups, the cut off points of health risk may 
differ across different populations (Tanko et al. 2002).
 Cigarette smoking, poor health, low body mass index 
(BMI) and low testosterone levels in men were several of 
the associated factors identified in the western population 
(Baumgartner et al. 1998). However, there is a paucity 
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of literature regarding risk factors of sarcopenia amongst 
Asians.
 Accumulation of reactive oxygen species throughout 
life is known to influence the ageing process. The 
mechanism by which reactive oxygen species accumulate 
and contribute to the aging of muscles involves the 
insufficient function of the respiratory chain, as well 
as mutations in mitochondrial DNA (Lau et al. 2005). 
The oxidative capacity of human muscles have been 
characterized between younger and older adults and is 
shown to decrease with age and muscle mass (Janssen 
et al. 2002). Previous studies, however, have not shown 
the relationship between hand grip strength and protein 
carbonyl levels in human plasma. In humans, elevated 
serum protein carbonyls levels have been described in the 
elderly compared to younger adults (Tanko et al. 2002). 
Indicators of oxidative damage to lipids and proteins could 
complement these investigations. However, very few 
studies have explored the influences of oxidative stress on 
sarcopenia. Therefore, this study aimed to investigate the 
magnitude of sarcopenia among Malaysian elderly and its 
association with health factors including oxidative stress 
and food intake. 
METHODOLOGY
STUDY DESIGN AND PARTICIPANTS
This is a cross-sectional study that was carried out from 
December 2008 until early May 2009. A total of 388 
subjects (39.9% men and 60% women) residing at 15 
low cost flats and houses managed by Kuala Lumpur 
City Hall, Cheras, Kuala Lumpur, Malaysia participated 
in this study through convenient sampling. The subjects 
were recruited with the help of the Housing Management 
Officer, residential representative, as well as through 
information from using posters, banners, invitation letters 
and informational lectures. The inclusion criteria also 
included individuals aged 60 years old and above, subjects 
with at least a duration of permanent residence of one 
year prior to the study with no terminal or mental illness. 
Written informed consent was obtained from all subjects. 
This study has been approved by the Medical Research 
and Ethics Committee of Universiti Kebangsaan Malaysia.
DEMOGRAPHY, LIFESTYLE AND ANTHROPOMETRY 
The subjects were gathered at community halls for 
anthropometry measurement, body composition and also 
interviewed for socio-demography and health profile. 
Screening questionnaires on demography details included 
gender, age, ethnics, marital status, education level, 
employment status and monthly household income. For 
lifestyle assessment, questions on smoking and self-
reported exercise practices were obtained. Assessment 
of food intake (Dietary Habits Questionaires) as well as 
appetite was assessed using CNAQ questionnaires. Handgrip 
strength using handgrip Dynamometer JAMAR 7498-05 
(JAMAR Sammons Preston, Inc, UK) to the nearest 0.1 kg 
was used. Anthropometry parameters were measured using 
TANITA digital lithium scale HD319, (TANITA Corporation, 
Japan) for body weight, using SECA Leicester Portable 
Height Measure (SECA, German) for height and waist 
circumference using SECA measuring tape (SECA, German). 
Maltron Bio-Scan 916 (Maltron International Ltd, UK) 
was used for estimation of body composition using bio-
impedance analysis method. 
DETERMINATION OF SARCOPENIA
Subjects were categorized as sarcopenia when the skeletal 
muscle mass index = (total skeletal muscle (kg) / height 
(m2)) value was below – 2 SD compared with young adults. 
The cut off points for Asian population that was used to 
classify sarcopenia is less than 10.75 kg/m2 in men and 
6.75 kg/m2 in women (Janssen et al. 2002). For moderate 
sarcopenia, the cut-off point is between 8.51 and 10.75 kg/
m2 in men and 5.76 and 6.75 kg/m2 in women. However, 
for severe sarcopenia the cut-off point for men is <8.50 
kg/m2 and <5.75 kg/m2 for women.
CLINICAL AND LABORATORY EXAMINATION
Clinical evaluation for hypertension and diabetes mellitus 
was conducted and the presence of chronic diseases 
was confirmed (self-reported, diagnosed by physician 
and identified current medication). A total of 10 mL 
venous blood sample was drawn from the antecubital 
vein in a seated position after an overnight fast. The 
samples were centrifuged at 28000 g for 5 min at 4°C 
and the clear supernatants were collected and stored at 
−30°C for plasma separation. Plasma was transferred 
in Eppendorf tubes and used for the oxidative stress 
markers determination of superoxide dismutase enzyme 
(Bayer & Fridovich 1987) and protein carbonyl (Buss 
et al. 1997). Lipid hydroperoxide was determined using 
kits by Cayman Chemicals (USA). Blood samples were 
stored in multiple aliquots at −30°C and thawed only 
once prior to analysis. Another portion of blood (10 
mL) was collected in plain tubes, left on ice for 20 min 
to clot and then centrifuged at 1500 g for 10 min at 4°C 
for serum separation. Serum was sent to the Gribbles 
Pathology Department for analysis of homocysteine, 
total cholesterol, HDL, LDL and glucose analysis using 
automated ADVIA 2400 from Siemens (USA).
STATISTICAL ANALYSIS
Statistical package for Social Sciences version 17 (SPSS, 
Inc, Chicago, IL) was used to analyze the data collected. 
Descriptive analyses were performed on demography, 
clinical and laboratory examinations. The prevalence of 
Sarcopenia between genders was presented in percentage. 
Pearson’s correlation test was carried out to compare 
the differences in the frequency of Sarcopenia among 
genders. Binary logistic regression analysis was used 
to simultaneously examine the relative predictors for 
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Sarcopenia among men and women. All tests were 2-tailed 
at a probability level of 0.05. 
RESULTS
GENERAL
The mean age of subjects were 66.4±5.7 years old with no 
differences between men (66.56±5.55 years) and women 
(66.7±6.24 years) ranging from 60 to 86 years. The 
prevalence of sarcopenia was 89.0% in men and 40.3% 
in women with the overall prevalence of 59.8% (Figure 
1). Most of the subjects were categorized as moderate 
sarcopenia with 72.9% prevalence in men and 27.9% in 
women. On one hand, severe sarcopenia in men was 16.1% 
and 12.4% in women. On the other hand, sarcopenia was 
categorized as sarcopenia lean with prevalence in men 
was 47.4% and 24.5% in women. Proportion of sarcopenia 
obese was 42.2% in men and 15.8% in women. 
FACTORS ASSOCIATED WITH SARCOPENIA INCIDENCE 
BETWEEN GENDER
The results from χ2 analyses to investigate the association 
between various independent variables and the incidence 
of sarcopenia between genders are shown in Table 1. The 
results indicated, that Diabetes and HDL were significantly 
associated with incidence of sarcopenia in men (p<0.05). 
For women, those who are more than 70 years (41.6% > 70 
years, 26.9% 60-70 years,) (Crude Odd Ratio (OR) 1.937); 
a 95% confidence interval (CI) 1.097-3.421; p=0.023) was 
found to be associated with women. Overall, age group 
more than 70 years (36.6% more than 70 years, 26.7% 
age between 60 and 70 years) (Crude OR 1.588; 95% CI 
1.010-2.497; p=0.045), being married (66.4% married, 
33.6% single/widow) (Crude OR 1.876; 95% CI 1.238-
2.842; p=0.003), hypercholesterolemia (66.3% high, 33.7% 
normal) (Crude OR 0.523; 95% CI 0.305-0.896; p=0.017) 
and hyperhomocysteine (52.5% hyperhomocysteine, 
31.9% normal) (Crude OR 1.930; 95% CI 1.190 – 3.129; 
p=0.007). However, binary logistic regression (Table 3) 
demonstrated an absence of predictors among men and 
women in this study.
BODY COMPOSITION, OXIDATIVE STRESS AND 
BIOCHEMICAL PARAMETERS FOR MEN AND WOMEN
The results showed that there were reductions in weight 
(men: 64.7±11.2; women: 52.3±10.99), BMI (men: 
24.8±3.8; women: 23.9±6.1) and waist circumference 
(men: 87.9±11.9; women: 79.7±13.7) in sarcopenic 
subjects compared with non sarcopenic subjects in both 
men and women (p<0.05). Sarcopenic subjects in both men 
and women have lower SMI (9.24 ± 0.99 in men and 5.98 
± 0.65 in women, p<0.05) than the non sarcopenic (Table 
2). The women also showed a lower level of fat free mass 
FIGURE 2. Prevalence of obese and lean sarcopenia according to gender
FIGURE 1. Prevalence of moderate and severe sarcopenia according to gender
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TABLE 2. Predictors of Sarcopenia by gender
Predictor Adjusted OR 95% CI β Pa
Men
Diabetes
HDL
0.614
4.535
0.118– 3.183
1.252 -  16.424
-0.488
1.512
0.561
0.121
Women
More than 70 years 0.470 0.204-1.803 -0.755 0.076
Overall
Married
More than 70 years
Hypercholesterolemia
Hyperhomocysteine
0.539
1.973
0.778
1.536
0.280 -1.040
0.992 – 3.921
0.367 – 1.648
0.794 – 2.973
-0.618
0.679
- 0.252
0.429
0.539
0.053
 0.511
0.203
a Data were analyzed using binary logistic regression
b significant differences  at p< 0.05
(FFM) among sarcopenic subjects (45.54±9.47), rather 
than non sarcopenic (51.56±15.23) (p<0.05). A similar 
trend was noted for the women where sarcopenic subjects 
(32.76±5.20) have lower levels of FFM compared with non 
sarcopenic subjects (36.43±9.36) (p<0.05). In relation 
to muscle mass, a decline was noted among sarcopenic 
subjects in both men and women (p<0.05). There was no 
difference observed for handgrip strength for both men 
and women in sarcopenic subjects (p>0.05).
 Table 3 also showed that there was no significant 
differences in measures oxidative parameters which 
consists of superoxide dismutase, protein carbonyl, lipid 
hydroperoxide and glutathione (p>0.05). Women also 
showed similar results as men (p>0.05) according to 
sarcopenia status in both men and women. 
FOOD INTAKE IN MEN AND WOMEN
With respect to nutrient intake, Table 4 shows all subjects 
regardless of their gender or sarcopenia status, did not meet 
the recommended nutrient intake for energy. A similar 
trend was noted for carbohydrate, thiamin, riboflavin, 
zinc and calcium. However, protein and iron intake was 
satisfactory. For men, it was also noted that there was a 
decline in carbohydrate intake in sarcopenic subjects as 
compared with normal subjects (p<0.05). For both men 
and women, energy and protein intake were also lower 
in the sarcopenic lean subjects. However, the differences 
were not significant. 
DISCUSSION
This present study apparently revealed that the prevalence 
of sarcopenia among elderly Malaysians was significantly 
higher than those documented in the west and other Asians 
countries. A study done by (Tanko et al. 2002) showed 
that there was a prevalence of 24% in women. For the 
Hispanic population, the prevalence was 18.3% in men 
and 35.1% in women. In contrast with non-Hispanic 
population, the prevalence was 19.8% in men and 33.3% 
in women (Baumgartner et al. 1998). For the Chinese 
population, it was found that the prevalence was 7.19% in 
men and 6.05% in women (Sowers et al. 2005). The large 
differences in values for sarcopenia incidence could be due 
to the variability in study design, sample size, geographical 
boundaries, background of subjects, method for assessing 
the skeletal muscle mass and different cut-off points used 
for the determination of sarcopenia. In Australia, the 
low prevalence of sarcopenia in men increased with age 
from 14% in those aged 70 to 74 to 58% in those aged 90 
and older was observed. In this study, muscle mass was 
measured using dual X-ray absorptiometry (DXA) and 
was defined as appendicular lean mass relative to height 
(aLM/height2) (Hairi et al. 2010). On the other hand, most 
of the other studies have used the cut-off points suggested 
by Baumgartner et al. (1998), which defined sarcopenia 
as having a relative skeletal muscle mass (RSMI) of less 
than 2.0 standard deviations below the young references 
group or less than 7.26 kg/m in men and less than 5.45 kg/
m2 in women. 
 However, this current study has employed the cut-off 
points used by Janssen et al. (2002), which considered the 
presence of moderate to high degree of Sarcopenia as that 
within the SMI values of <10.75 kg/m2 in men and <6.75 kg/
m2 in women was used. For moderate sarcopenia the cut-off 
points between 8.51 and 10.75 kg/m2 in men and 5.76 and 
6.75 kg/m2 in women. However, for severe sarcopenia the 
cut-off points for men was <8.50 kg/m2 and for women was 
<5.75 kg/m2. These cut-off points have been used because 
they were associated with elevated physical disability risk. 
These cut-off values derived in the present study is whole 
body muscle mass, which can be estimated using a variety 
techniques that included magnetic resonance imaging, 
total body potassium counting, bioimpedance analysis 
and anthropometry. It is also noted that the skeletal muscle 
mass cut-off points determined using this current cut-off 
points are similar to the arbitrary cut-off points determined 
in previous studies (Janssen et al. 2002).
 The prevalence of sarcopenia in this study was 89.0% 
in men and 40.3% in women with the overall prevalence 
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 TABLE 3. Differences in anthropometry, body composition, functional status and biochemical indicators 
in men and women according to sarcopenia status 
 Men Women
Normal Sarcopenia P a Normal Sarcopenia P a
Number 
Weight (kg)
BMI (kg/m2)
Waist Circumference 
 (cm)
Fat Free Mass  (kg)
% Fat
Muscle (kg)
ECW (kg)
ICW (kg)
Handgrip (kg)
SMI  (kg/m2)
Number
SOD (specific activity)
Protein Carbonyl 
 (nmol/L)
LPO (pg/mL)
Glutathione(μmol/L)
Homocysteine 
 (μmol/L)
Total cholesterol 
 (mmol/L)
HDL (mmol/L)
LDL (mmol/L)
Glucose (mmol/L)
HBA1C(%)
17
86.95 ± 24.1
31.76 ± 4.40
102.267 ± 9.60
51.56 ± 15.23
34.13 ± 11.08
25.03 ± 7.56
19.93  ± 4.49
24.5 ± 5.88
20.94  ± 7.90
11.86 ± 2.61
11
1.73  ± 1.15
1.28 ± 0.69
3.80 ± 1.19
1.09 ± 0.64
19.71 ± 4.20
5.67 ± 1.13
1.09 ± 0.19
3.47 ± 0.86
6.05 ± 1.64
6.81 ± 1.86
138
64.74 ± 11.29
24.81 ± 3.79
87.99 ±11.89
45.54  ± 9.47
29.58  ± 5.85
21.41  ± 5.42
16.79  ± 4.30
19 .11 ± 3.95
19.77 ± 7.98
9.24 ± 0.99
109
1.74 ± 0.94
1.20 ± 0.52
3.58 ±1.07
1.00 ± 0.48
22.02 ± 6.33
5.53 ± 0.99
2.39±12.04
3.60 ± 0.87
6.70 ± 3.21
6.45 ± 1.47
0.000 b
0.000 b
 0.000 b
0.027 b
 0.000 b
0.017 b
 0.011 b
 0.000 b
 0.578
 0.000 b
 
0.962
0.661
0.468
0.592
0.226
0.042 b
0.723
0.652
0.508
0.455
139
63.91 ± 10.66
28.62 ± 4.43
89.21 ± 9.16
36.43 ±9.36
38.25 ±11.91
15.70 ± 4.78
16.95 ± 1.64
19.93 ± 2.55
13.27 ± 6.90
8.24 ±3.74
108
1.86 ± 0.99
1.37 ± 1.00
4.59 ± 4.65
1.07 ±0.52
19.71 ± 6.87
5.99 ± 1.12
1.44 ± 0.32
3.83 ± 0.99
6.19 ± 2.28
6.42 ± 1.56
94
52.28 ± 10.99
23.94 ± 6.08
79.69 ±13.69
32.76 ± 5.20
36.02 ± 10.10
14.14 ± 2.66
12.47 ± 1.31
14.67 ±2.20
14.38 ± 1.67
5.98 ± 0.65
72
1.77 ± 0.72
1.41 ± 1.23
3.96 ± 1.54
0.99 ± 0.45
20.88 ± 6.59
6.01 ± 1.16
1.57 ± 0.45
3.83 ±1.07
6.24 ± 2.55
6.32 ± 1.45
0.000 b
0.000 b
0.000 b
0.001 b
0.137
0.004 b
0.025 b
0.089
0.479
0.000 b
0.515
0.786
0.253
0.355
0.260
 
0.917
0.020 b
0.942
0.888
0.654
a independent sample t-test 
b significant differences between normal and sarcopenic subjects (p<0.05). BMI = Body Mass Index, ECW =Extracellular water, ICW =Intracellular Water, 
 SMI = Relative Skeletal Muscle Index , SOD = Superoxide dismutase enzyme, LPO = Lipid hydroperoxide
of 59.8%. The prevalence of moderate sarcopenia was 
72.9% and severe sarcopenia was only 16.1% in men while 
in women moderate sarcopenia was 27.9% and severe 
sarcopenia was 12.4%. Sarcopenia lean was 47.4% in men 
and 24.5% in women, while sarcopenia obese in men was 
42.2% and 15.8% in women. As compared with the study 
by Janssen et al. (2002), the prevalence in the current 
study was higher in both moderate and severe sarcopenia. 
However, a similar trend was found in this study where 
men showed the higher prevalence compared to women.
In terms of gender, the current study revealed for those 
who are more than 70 years old there are differences 
in its association with sarcopenia. This is in line with 
previous studies which found that sarcopenia prevalence 
for less than 70 years was 13 to 28% and more than 70 
years old was over 50% (Timothy 2003). A similar trend 
was found by Morley et al. (2001) who observed that 
in women, the percentage of subjects with sarcopenia 
increased from 8.8% in those less than 70 years to about 
16% in those older than 70 years. A person’s marital status 
was also observed to be associated with the incidence 
of sarcopenia. Sarcopenic subjects without spouse are 
deemed to be deficient of companionship, are discouraged 
from participating in extraneous activities and are lack 
perceived social support especially in doing exercise or 
any physical activities (Lee et al. 2012). The current study 
also observed an association between hypercholesterolemia 
and hyperhomocysteinemia and with the occurrence 
of sarcopenia in the population regardless of gender. 
However, the mechanism underlying the possible role 
of cholesterol and homocysteine with the occurrence of 
sarcopenia remain unknown. Further research may attempt 
to investigate the possible mechanism of cholesterol and 
homocysteine in accelerating sarcopenia in elderly people. 
This study also found decline in level of muscle mass 
and FFM in sarcopenic subjects as compared with normal 
subjects, thereby supporting the fact that there will be 
decreased in muscle mass and muscle strength with ageing. 
The loss of muscle mass with age may be attributed to 
the loss of anabolic factors such as neural growth factors, 
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growth hormones, physical activity and inflammation 
of cytokines. Meanwhile, a decline in protein synthesis 
and mitochondrial dysfunction might reduce endurance 
capacity and possibly loss of strength in elderly related to 
aging. In this study, a decline in FFM and an increase in 
fat mass can lead to the incidence of sarcopenic obesity 
in the population. However, it was found that prevalence 
of sarcopenic lean was higher. This finding might be due 
to the fact that sarcopenic obese subjects had difficulty in 
attending the screening phase at the community hall as it 
was on a voluntary basis. 
 As expected, we found a totally different conceptual 
factor to predict sarcopenia occurrence. Among men and 
women, there were no statistically significant associations 
between any of the variables and sarcopenia. The current 
study is in contrast to Lee et al. (2007), which found 
an association between underweight and sarcopenia 
incidence. However, in a study by Noran et al. (2010), it 
was found that high body fat and high BMI values were 
associated with a greater likelihood of functional limitation 
in a population of elderly women. These differences may be 
due to significant cultural and socioeconomic differences 
between the study populations.
 In addition, this current study revealed that the body 
weight, BMI and waist circumference was lower among 
sarcopenic as compared with normal subjects in both men 
and women. The loss of muscle mass in tandem with weight 
loss in the elderly will cause serious functional disabilities 
and limitations in their daily lives’. Muscle strength and 
muscle mass both deteriorate with age (Zamboni et al. 
2007). However, the causes of these decreases in muscle 
strength and mass are not well documented and will need 
further clarification.
 In the human skeletal muscle, proteins, DNA and lipids 
are damaged by reactive oxygen species during oxidative 
stress. The levels of these damaged macromolecules and 
lipids increase with age. Protein carbonyls are known 
markers of oxidative stress and accumulate with ageing. 
Protein carbonylation leads to cellular dysfunction 
and a decline in tissue function and is involved in the 
pathogenesis of sarcopenia (Sowers et al. 2005). Although 
oxidative stress has been implicated in the pathogenesis 
of sarcopenia, the relationship between oxidative stress 
and physical performance has not been well documented. 
Hence, this current study observed the associations 
between oxidative stress and incidence of sarcopenia. 
However, there were no significant differences observed 
between the sarcopenia incidences with the oxidative 
parameters. The finding of nutrient intake in this current 
study showed that level of antioxidant intake, mainly 
Vitamin C, meets the RNI in this population. There were 
no significant difference for both normal and sarcopenic 
subjects. This antioxidant intake may play a major role as a 
scavenger for free radical attack and may prevent lipid and 
protein oxidation. These finding were contrary to Semba et 
al. (2007), which showed there was a relationship between 
protein carbonyl and severe walking disability which are 
closely related with sarcopenia. Hence, in relation to the 
oxidative stress the findings showed that it may increase 
the risk of sarcopenia incidence. The differences may 
be due to the background of population which is more 
than 65 years old and the difference in cut-off points of 
subjects. Data regarding oxidative stress and sarcopenia 
are limited and the mechanisms underlying this remains 
controversial. However, initial evidence stating that 
excessive oxidative stress is involved in the pathogenesis of 
age-related sarcopenia and subsequent decrease of strength 
and mobility should be further investigated.
 There are several mechanisms underlying sarcopenia 
problems such as poor nutrition and physical inactivity 
in this population. The level of physical activity in 
this population study was not much different between 
sarcopenic and normal subjects. However, it was observed 
that the energy intake for this population did not meet the 
requirement for RNI for all subjects and this may accelerate 
the process of sarcopenia. 
 The present work has several strengths. First, it is 
the first study to specifically investigate the influence of 
gender disparities to predict the occurrence of Sarcopenia 
among multiethnic elderly population, thereby bridging 
the research gap in the pool of currently available data. 
Second, the participants were non-institutionalized, 
which allows direct extrapolation to older persons of the 
population at large with investigation of various potential 
risk factors (ranging from socio-demographic background, 
lifestyle practices, health status and clinical aspects). These 
volunteers who are living independently were interested 
in this study and may represent those who were more 
educated and healthier within the general population. 
However, the major limitation in the present study is 
that it was cross sectional and therefore cannot provide 
evidence for a causal relationship between predictors and 
Sarcopenia. The validity and reliability of the self-reported 
variables for socioeconomics, diseases, smoking, physical 
activities, food intake are not known. The self-reported data 
may be subject to significant cultural and socioeconomic 
influences, which might also influence the findings of this 
study. Finally, bioelectrical impedance analysis has been 
employed to estimate muscle mass and previous studies 
have noted inaccuracies in its use to assess lean body mass 
in the elderly, which may in part be caused by changes in 
the hydration of lean mass and the cylindrical shape of the 
appendicular muscles.
CONCLUSION
In summary, the present work documents at high 
prevalence (59.8%) of sarcopenia among elderly people 
in Malaysia with the highest incidence of moderate 
sarcopenia in both men and women. The findings revealed 
no absence of predictor in men and women. However, 
decline in body weight, muscle mass and FFM were 
observed among sarcopenic subjects. This could imply 
that in our population, further investigations should be 
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done to confirm the controversial issue of the occurrence 
of sarcopenia in both men and women. The clinical 
significance of these predictors as well as pathophysiology 
of the skeletal muscle and inflammatory mediators among 
the Malaysian elderly will need further investigations. 
Possibly, a physical therapy intervention may help improve 
muscle strength among this affected group and thus 
assist towards improvement of functional performance 
in activities of daily living as well as their quality of life.
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